Market Research Industry Reports

Leap Therapeutics Inc (LPTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Leap Therapeutics Inc (Leap Therapeutics) is a clinical-stage biopharmaceutical company that acquires, develops novel therapeutics for cancer research. The companys pipeline encompasses DKN-01, a humanized monoclonal antibody that targets the Dickkopf-1 (DKK-1) protein, and in clinical trials for the treatment of in esophageal cancer, cholangiocarcinoma, a form of bile duct cancer; and non-small cell lung cancer. Its TRX518, is a humanized anti-GITR (glucocorticoid-induced tumor necrosis factor receptor) monoclonal antibody that enhances the immune systems anti-tumor response and is in Phase 1 clinical trials for the treatment of solid tumors. Leap Therapeutics is headquartered in Cambridge, Massachusetts, the US.

Leap Therapeutics Inc (LPTX) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.




Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Leap Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Leap Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
GITR Raises US$3.25 Million In Seed Financing 12
Partnerships 13
Leap Therapeutics Enters into Immunotherapy Agreement with European Organisation for Research and Treatment of Cancer 13
Leap Therapeutics Enters into Agreement with Merck International 14
Merger 15
GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 15
Equity Offering 16
Leap Therapeutics Raises USD16.1 Million in Public Offering of Shares 16
Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 18
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 19
Macrocure Completes IPO for USD54 Million 20
Acquisition 22
Leap Therapeutics Acquires Macrocure 22
Leap Therapeutics Inc - Key Competitors 24
Leap Therapeutics Inc - Key Employees 25
Leap Therapeutics Inc - Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Feb 23, 2018: Leap Therapeutics Reports Fourth Quarter and Full Year 2017 Financial Results 27
Nov 13, 2017: Leap Therapeutics Reports Third Quarter 2017 Financial Results 29
Aug 11, 2017: Leap Therapeutics Reports Second Quarter 2017 Financial Results 30
May 12, 2017: Leap Therapeutics Reports First Quarter 2017 Financial Results 31
May 12, 2017: Leap Therapeutics Q1 net loss increases 32
Mar 31, 2017: Leap Therapeutics Reports Full Year 2016 Financial Results and Progression-Free Survival Data in Advanced Biliary Tract Cancers 33
Product News 35
03/01/2017: Leap Therapeutics to Present Clinical Data on TRX518 at 2017 AACR Annual Meeting 35
02/03/2017: Leap Therapeutics Presents Biomarker and Efficacy Data at the Cholangiocarcinoma Foundation 2017 Annual Meeting 36
01/19/2017: Leap Therapeutics Presents Biomarker Data from Clinical Study of DKN-01 in Combination with Paclitaxel in Esophageal Cancer 37
Clinical Trials 38
Apr 03, 2017: Leap Therapeutics Presents Non-clinical and Phase 1 Data for TRX518 at the 2017 AACR Annual Meeting 38
Appendix 39
Methodology 39
About GlobalData 39
Contact Us 39
Disclaimer 39

List Of Tables

List of Tables
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Leap Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Leap Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Leap Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
GITR Raises US$3.25 Million In Seed Financing 12
Leap Therapeutics Enters into Immunotherapy Agreement with European Organisation for Research and Treatment of Cancer 13
Leap Therapeutics Enters into Agreement with Merck International 14
GITR Merges with HealthCare Pharmaceuticals to Form Leap Therapeutics 15
Leap Therapeutics Raises USD16.1 Million in Public Offering of Shares 16
Leap Therapeutics Plans to Raise Funds in Secondary Offering of Shares 18
Leap Therapeutics to Raise USD18 Million in Private Placement of Units 19
Macrocure Completes IPO for USD54 Million 20
Leap Therapeutics Acquires Macrocure 22
Leap Therapeutics Inc, Key Competitors 24
Leap Therapeutics Inc, Key Employees 25
Leap Therapeutics Inc, Subsidiaries 26

List Of Figures

List of Figures
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Leap Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Leap Therapeutics Inc, Medical Devices Deals, 2012 to YTD 2018 10

Leap Therapeutics Inc (LPTX) - Pharmaceuticals and Healthcare - Deals and Alliances Profile

Leap Therapeutics Inc (Leap Therapeutics), formerly HealthCare Pharmaceuticals Inc, is a clinical-stage biopharmaceutical company that develops novel therapeutics to treat patients with cancer. The companys pipeline products include DKN-01, a

USD 250View Report

LEAP Holdings Group Limited Company Profile - Business Operations, Strategies, SWOT Analysis and Financial Report

LEAP Holdings Group Limited Company Profile is a detailed strategic and analytical report on LEAP Holdings Group Limited. The 2018 version of the report offers detailed insights into the companys

USD 200View Report

Agile Therapeutics Inc (AGRX) - Medical Equipment - Deals and Alliances Profile

Agile Therapeutics Inc (Agile) is a healthcare company that develops and commercializes prescription contraceptive products for women. The company provides contraceptive patch containing the active ingredients levonorgestrel and ethinyl estradiol

USD 250View Report

C3J Therapeutics Inc - Pharmaceuticals and Healthcare - Deals and Alliances Profile

C3J Therapeutics Inc (C3J), formerly C3 Jian Inc is a clinical-stage biotechnology company that offers discovery and development of novel targeted antimicrobials, synthetic bacteriophage and antimicrobial peptides. Its pipeline products

USD 250View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Apr 2018
No. of Pages :39
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube